about
Aclidinium bromide for the treatment of chronic obstructive pulmonary diseaseLong-acting inhaled bronchodilators for cystic fibrosisLong-acting beta 2 -agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary diseasePatient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthmaDual therapy strategies for COPD: the scientific rationale for LAMA + LABACOPD: the patient perspectiveSpecific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary diseaseDifferential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterolPharmacology of novel treatments for COPD: are fixed dose combination LABA/LAMA synergistic?Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDClinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of lifeProfile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPDThe pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder diseaseIs there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?Muscarinic acetylcholine receptor X-ray structures: potential implications for drug developmentCombination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseNew combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectivesEfficacy of tiotropium-olodaterol fixed-dose combination in COPDASM-024, a piperazinium compound, promotes the in vitro relaxation of β2-adrenoreceptor desensitized tracheasMuscarinic antagonists in early stage clinical development for the treatment of asthma.Investigating lung responses with functional hyperpolarized xenon-129 MRI in an ex vivo rat model of asthmaReal-world health care utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir ® HFA) with and without integrated dose countersThe in vivo efficacy and side effect pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long-acting β 2-adrenoceptor agonist in preclinical animal species.COPD: maximization of bronchodilation.Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised studyA dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.Is there a rationale and role for long-acting anticholinergic bronchodilators in asthma?Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthmaPharmacogenomics of long-acting β2-agonists.Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD.Anti-Inflammatory Effects of β2-Receptor Agonists Salbutamol and Terbutaline Are Mediated by MKP-1.Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial.Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD.Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses.Efficacy of acupuncture for chronic asthma: study protocol for a randomized controlled trialGFF MDI for the improvement of lung function in COPD - A look at the PINNACLE-1 and PINNACLE-2 data and beyond.Indacaterol: a comprehensive review.Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation.New developments in the management of COPD: clinical utility of indacaterol 75 μg.
P2860
Q22306019-F1F45009-8E82-481C-807E-E4C72972008EQ24186191-BE33A1CB-AB6A-46A5-AEC6-69E31964B6DFQ24194044-D0ADF40F-DA6E-438C-9136-BD4B17A62347Q26743444-8AF0287B-70EA-4150-BA72-75CBE1F1CA96Q26752988-720927FC-8D06-4816-9115-A84B922C87C9Q26764894-1E643FB0-D53E-4210-8DCF-8B276438702AQ26770504-2AF93661-567A-43A2-A47D-E40404147977Q26775244-440E3F90-1A51-444A-892F-674412C9FEC0Q26777927-ACBD78C5-3401-46F3-85C4-6786E7A4827EQ26778685-4CEB276C-3020-479F-B429-CFF884373141Q26801134-95A542DF-DA54-4683-8048-0188368E90E6Q26825822-CE9AA412-78A4-427D-AA36-062126D8D867Q26864937-92EC3E38-C1CB-4135-BE8C-D4AC50FE46CEQ26998459-5562BA11-61A5-48BB-AE8C-89F734928007Q26999429-1FDC8262-A049-49C7-8CE1-F3D257CB6ABBQ27012625-B56F50ED-1131-417B-8D83-109C45290928Q27024384-559BBD1B-F0BD-49D2-B838-D06F4E9E5DD8Q28075367-22B261B1-6477-46CA-8308-7E8090435416Q28544879-71BED8AB-A1B8-48D2-874F-EE108B259442Q30396144-F448777F-0970-430D-889F-8DCA717A1149Q30488473-0FE31684-C5B5-4962-9870-4F1504AD8916Q33713976-B75B0A2A-B640-4F91-96CF-A0C0D22430A7Q34292566-AF494EEF-6222-435C-B768-344AFFF5523BQ34436393-E1C9530D-4602-4C1D-B2F9-DCD335931920Q34753755-69C6D3A2-6D32-41E4-B89E-2EDE63F423EFQ35060604-DB3834E8-96E2-424F-B6B4-570B7DC42ACAQ35216188-A4576B1D-F131-4436-98C1-16432B01304CQ35538249-7D8B5148-94B5-435A-BD0F-BC93EA7FA12FQ35694500-803D3D36-38E8-49FA-ADCC-AE04CA4CC271Q35734012-1B537471-09C1-4C27-8E74-A2C97BC76BCBQ35766346-C8A23813-1C79-487A-AA9E-3E612052E7B4Q35915798-00089293-E41B-46B7-83D9-4F799D097FD5Q36018687-7C2C28DB-99F9-4C75-BECE-6B55E9951337Q36083119-D89A8821-6D5B-4091-A5DF-5F07F5BD5208Q36084073-15C154BF-C28F-4644-A7EC-EB61DE14F429Q36088059-F06109B9-0BFE-48C2-8094-B7DA1DC71A33Q36356295-766EEFFC-757D-45FC-8296-E678501F306BQ37057061-B3990722-5FB2-459E-92A0-579B37F4AF29Q37368923-250F4C14-89B7-4739-9776-84F0ACFC1EEEQ37390883-B71F731E-0F2B-4ECB-A70D-562536B21DD2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacology and therapeutics of bronchodilators.
@en
type
label
Pharmacology and therapeutics of bronchodilators.
@en
prefLabel
Pharmacology and therapeutics of bronchodilators.
@en
P2093
P356
P1476
Pharmacology and therapeutics of bronchodilators.
@en
P2093
Clive P Page
Luigino Calzetta
M Gabriella Matera
Mario Cazzola
P304
P356
10.1124/PR.111.004580
P577
2012-05-18T00:00:00Z